| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 24,1 M € | +3.7% | 23,3 M € | +4.9% | 22,2 M € | +9.0% | 20,4 M € | -4.9% | 21,4 M € | +47.5% | 14,5 M € | +1.6% | 14,3 M € | -11.1% | 16,1 M € | +27.6% | 12,6 M € | -8.2% | 13,7 M € | +10.1% | 12,5 M € | +2.3% | 12,2 M € | +4.9% | 11,6 M € | +12.5% | 10,3 M € | +12.5% | 9,2 M € | +11.1% | 8,3 M € | +15.2% | 7,2 M € | +9.8% | 6,5 M € | |
| EBITDA | 5,6 M € | +17.0% | 4,8 M € | +13.5% | 4,2 M € | +9.3% | 3,8 M € | +4.6% | 3,7 M € | +149.1% | 1,5 M € | +41.3% | 1,0 M € | +22.0% | 855,6 k € | -4.5% | 895,5 k € | -24.4% | 1,2 M € | -16.2% | 1,4 M € | -27.6% | 1,9 M € | -11.8% | 2,2 M € | +39.9% | 1,6 M € | +15.2% | 1,4 M € | +5.6% | 1,3 M € | +36.0% | 954,4 k € | +27.0% | 751,3 k € | |
| Operating profit | 5,6 M € | +17.0% | 4,8 M € | +13.4% | 4,2 M € | +9.3% | 3,8 M € | +4.6% | 3,7 M € | +149.9% | 1,5 M € | +41.3% | 1,0 M € | +19.8% | 866,9 k € | -0.2% | 869,0 k € | -26.1% | 1,2 M € | -16.4% | 1,4 M € | -27.5% | 1,9 M € | -12.1% | 2,2 M € | +40.0% | 1,6 M € | +15.3% | 1,4 M € | +5.5% | 1,3 M € | +36.6% | 947,9 k € | +25.9% | 753,2 k € | |
| Profit/loss | 4,2 M € | +18.4% | 3,6 M € | +6.9% | 3,3 M € | +17.0% | 2,9 M € | +4.8% | 2,7 M € | +202.9% | 899,3 k € | +36.4% | 659,5 k € | +20.4% | 547,8 k € | -0.7% | 551,8 k € | -27.7% | 763,2 k € | -17.1% | 921,2 k € | -28.1% | 1,3 M € | -13.0% | 1,5 M € | +43.0% | 1,0 M € | +14.4% | 900,0 k € | +6.4% | 845,7 k € | +38.0% | 613,0 k € | +24.9% | 490,8 k € | |
| Equity | 707,0 k € | +4.4% | 677,0 k € | +55.3% | 435,8 k € | +2.5% | 425,1 k € | +1.1% | 420,6 k € | +2.7% | 409,4 k € | -61.0% | 1,1 M € | +12.8% | 930,6 k € | -0.2% | 932,8 k € | -18.2% | 1,1 M € | -12.1% | 1,3 M € | -21.7% | 1,7 M € | -10.2% | 1,8 M € | +31.6% | 1,4 M € | +11.1% | 1,3 M € | +5.0% | 1,2 M € | +24.4% | 967,0 k € | +14.6% | 844,0 k € | |
| Total assets | 8,8 M € | +33.7% | 6,6 M € | +4.2% | 6,3 M € | +16.5% | 5,4 M € | +12.3% | 4,8 M € | +74.9% | 2,8 M € | -1.1% | 2,8 M € | -26.4% | 3,8 M € | -24.0% | 5,0 M € | +1.7% | 4,9 M € | +30.9% | 3,8 M € | +11.5% | 3,4 M € | -5.2% | 3,6 M € | +7.7% | 3,3 M € | +24.4% | 2,6 M € | +14.4% | 2,3 M € | -5.5% | 2,5 M € | +39.2% | 1,8 M € | |
| Cash | — | 0,0 € | 0,0 € | 0,0 € | -100.0% | 357,0 € | -81.9% | 2,0 k € | +62.7% | 1,2 k € | +255.7% | 341,0 € | -32.5% | 505,0 € | +3.1% | 490,0 € | +860.8% | 51,0 € | -72.9% | 188,0 € | -40.7% | 317,0 € | +734.2% | 38,0 € | -92.9% | 535,0 € | -98.4% | 34,3 k € | +1423.0% | 2,3 k € | -97.7% | 99,6 k € | ||||
| Debts | 8,1 M € | +37.0% | 5,9 M € | +0.4% | 5,9 M € | +17.7% | 5,0 M € | +13.4% | 4,4 M € | +87.5% | 2,4 M € | +35.0% | 1,7 M € | -39.2% | 2,9 M € | -29.5% | 4,1 M € | +12.2% | 3,6 M € | +51.3% | 2,4 M € | +47.7% | 1,6 M € | -2.3% | 1,7 M € | -8.0% | 1,8 M € | +36.1% | 1,3 M € | +26.3% | 1,0 M € | -28.6% | 1,5 M € | +63.2% | 900,8 k € | |
| Staff | 14,8 | 13,9 | 14,8 | 13,6 | 13 | 13,3 | 13,5 | 12,6 | 12,6 | 11,9 | 11 | 10,9 | 10,8 | 10,8 | 10,7 | 10,7 | 10,1 | 10,8 | ||||||||||||||||||
Public limited company profitable but thinly capitalised.
Solid counterparty for a standard engagement.
VIRBAC BELGIUM is a Public limited company incorporated in 1994. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Leuven. It employs on average 14,8 ETP workers (FTE).
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette